Desguerre, Isabelle
Hôpital Necker-Enfants Malades · Assistance Publique – Hôpitaux de Paris
8 papers on CoChatORCID 0000-0002-4074-5862
Most cited papers
- Verified
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics
RNA regulation and diseaseinterferon and immune responses
Cited by 923
- Verified
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy
Barcia, G., Fleming, M. R., Deligniere, A., Gazula, V.-R., Brown, M. R., Langouet, M., Chen, H., Kronengold, J., Abhyankar, A., Cilio, R., et al. (2012) · Nature Genetics
Epilepsy research and treatmentIon channel regulation and function
Cited by 525
- Verified
Fatal thrombotic microangiopathy case following adeno-associated viral SMN gene therapy
Guillou, J., de Pellegars, A., Porcheret, F., Frémeaux-Bacchi, V., Allain-Launay, E., Debord, C., Denis, M., Péréon, Y., Barnérias, C., Desguerre, I., et al. (2022) · Blood Advances
Complement system in diseasesVirus-based gene therapy research
Cited by 166
- Verified
Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome
Rice, G. I., Meyzer, C., Bouazza, N., Hully, M., Boddaert, N., Semeraro, M., Zeef, L. A. H., Rozenberg, F., Bondet, V., Duffy, D., et al. (2018) · New England Journal of Medicine
HIV/AIDS drug development and treatmentImmunodeficiency and Autoimmune Disorders
Cited by 153
- Verified
Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation
Drecourt, A., Babdor, J., Dussiot, M., Petit, F., Goudin, N., Garfa-Traoré, M., Habarou, F., Bole-Feysot, C., Nitschké, P., Ottolenghi, C., et al. (2018) · The American Journal of Human Genetics
Neurological diseases and metabolismIron Metabolism and Disorders
Cited by 100
- Verified
A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management
Lagrue, E., Dogan, C., De Antonio, M., Audic, F., Bach, N., Barnerias, C., Bellance, R., Cances, C., Chabrol, B., Cuisset, J.-M., et al. (2019) · Neurology
Genetic Neurodegenerative DiseasesGenetics and Neurodevelopmental Disorders
Cited by 76
- Verified
Multidisciplinary consensus recommendations from a European network for the diagnosis and practical management of patients with incontinentia pigmenti
Bodemer, C., Diociaiuti, A., Hadj‐Rabia, S., Robert, M. P., Desguerre, I., Manière, M. ‐., de la Dure‐Molla, M., De Liso, P., Federici, M., Galeotti, A., et al. (2020) · Journal of the European Academy of Dermatology and Venereology
Genetic and rare skin diseases.Dermatology and Skin Diseases
Cited by 59
- Verified
Clinical, cellular, and neuropathological consequences of AP1S2 mutations: further delineation of a recognizable X-linked mental retardation syndrome
Borck, G., Mollà-Herman, A., Boddaert, N., Encha-Razavi, F., Philippe, A., Robel, L., Desguerre, I., Brunelle, F., Benmerah, A., Munnich, A., et al. (2008) · Human Mutation
Genetics and Neurodevelopmental DisordersCellular transport and secretion
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free